Percutaneous ventricular assist devices (pVADs) are increasingly being used because of
improved experience and availability. The Impella (Abiomed), a percutaneous microaxial …

The use of mechanical circulatory support using percutaneous ventricular assist devices
(pVAD) has increased rapidly during the last decade without substantial new evidence for …

Cardiogenic shock (CS) is a time-sensitive and hemodynamically complex syndrome with a
broad spectrum of etiologies and clinical presentations. Despite contemporary therapies, CS …

Purpose To develop a mathematical model for predicting shear-induced von Willebrand
factor (vWF) function modification which can be used to guide ventricular assist devices …

Aims Bleeding and thrombotic complications compromise outcomes in patients undergoing
percutaneous mechanical circulatory support (pMCS) with veno-arterial extracorporeal …

Summary von Willebrand Factor (VWF) destruction is common with current heart pumps.
This study evaluates VWF activity with ModulHeart, a novel device using 3 micropumps in …

Monitoring of the patient supported with a temporary mechanical circulatory support (tMCS)
is crucial in achieving the best possible outcome. Monitoring is a continuous and labour …

Cardiogenic shock (CS) is a complex clinical syndrome with a high risk of mortality. The
recent, rapid development of temporary mechanical circulatory support (tMCS) has altered …

Bleeding and thrombotic complications are the main cause of morbidity and mortality in
critically ill patients on the intensive care unit (ICU), receiving short-term percutaneous …

Acute myocarditis presenting with cardiogenic shock, also termed fulminant myocarditis
(FM), 1, 2 represents 3% to 9% of adult patients admitted with acute myocarditis. 3, 4 …